These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30964153)

  • 1. Resolution of a case of denosumab-related osteonecrosis of the jaw after tooth extraction.
    Bujaldón-Rodríguez R; Gómez-Moreno G; Leizaola-Cardesa IO; Aguilar-Salvatierra A
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2314-2317. PubMed ID: 30964153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.
    Matsumoto A; Sasaki M; Schmelzeisen R; Oyama Y; Mori Y; Voss PJ
    Clin Oral Investig; 2017 Jan; 21(1):127-134. PubMed ID: 26924135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Denosumab-related osteonecrosis of the jaw after tooth extraction and the effects of a short drug holiday in cancer patients: a multicenter retrospective study.
    Hasegawa T; Ueda N; Yamada SI; Kato S; Iwata E; Hayashida S; Kojima Y; Shinohara M; Tojo I; Nakahara H; Yamaguchi T; Kirita T; Kurita H; Shibuya Y; Soutome S; Akashi M;
    Osteoporos Int; 2021 Nov; 32(11):2323-2333. PubMed ID: 33997909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive Oral Procedures and Events in Postmenopausal Women With Osteoporosis Treated With Denosumab for Up to 10 Years.
    Watts NB; Grbic JT; Binkley N; Papapoulos S; Butler PW; Yin X; Tierney A; Wagman RB; McClung M
    J Clin Endocrinol Metab; 2019 Jun; 104(6):2443-2452. PubMed ID: 30759221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Report of a jaw osteonecrosis possibly caused
by denosumab.
    Saad D; Saad P
    Eur J Oral Implantol; 2017; 10(2):213-222. PubMed ID: 28555210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteonecrosis of the jaw in a male osteoporotic patient treated with denosumab.
    Neuprez A; Coste S; Rompen E; Crielaard JM; Reginster JY
    Osteoporos Int; 2014 Jan; 25(1):393-5. PubMed ID: 23835864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Denosumab-related osteonecrosis of the jaw: A retrospective study.
    Egloff-Juras C; Gallois A; Salleron J; Massard V; Dolivet G; Guillet J; Phulpin B
    J Oral Pathol Med; 2018 Jan; 47(1):66-70. PubMed ID: 28977694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Denosumab-related osteonecrosis of the jaw.
    Diz P; López-Cedrún JL; Arenaz J; Scully C
    J Am Dent Assoc; 2012 Sep; 143(9):981-4. PubMed ID: 22942143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug-induced osteonecrosis of the jaw - not just bisphosphonates].
    Finkelshteyn A; Yarom N
    Refuat Hapeh Vehashinayim (1993); 2017 Jan; 34(1):32-35, 72. PubMed ID: 30699493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Denosumab-related osteonecrosis of the jaw following non-surgical periodontal therapy: A case report.
    Diniz-Freitas M; Fernández-Feijoo J; Diz Dios P; Pousa X; Limeres J
    J Clin Periodontol; 2018 May; 45(5):570-577. PubMed ID: 29479739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Denosumab-related osteonecrosis of the jaw: a report of 2 cases and review of the literature.
    Chehal H; Nikitakis NG; Islam MN; Goodchild JH; Mordini L; Bhattacharyya I
    Gen Dent; 2019; 67(1):42-46. PubMed ID: 30644830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Denosumab: a case of MRONJ with resolution.
    Lyttle CV; Patterson H
    Br Dent J; 2016 Jun; 220(12):623-5. PubMed ID: 27338901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?
    Soutome S; Hayashida S; Funahara M; Sakamoto Y; Kojima Y; Yanamoto S; Umeda M
    PLoS One; 2018; 13(7):e0201343. PubMed ID: 30048523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasonic Piezoelectric Bone Surgery Combined With Leukocyte and Platelet-Rich Fibrin and Pedicled Buccal Fat Pad Flap in Denosumab-Related Osteonecrosis of the Jaw.
    Şahin O; Odabaşi O; Ekmekcioğlu C
    J Craniofac Surg; 2019 Jul; 30(5):e434-e436. PubMed ID: 31299805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral cutaneous sinus tract, vertical root fracture, and bisphosphonate-related osteonecrosis: a case report.
    Wigler R; Steinbock N; Berg T
    J Endod; 2013 Aug; 39(8):1088-90. PubMed ID: 23880284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful conservative treatment of jaw osteonecrosis caused by denosumab in patients with multiple bone metastasis.
    Ohga N; Sato J; Asaka T; Morimoto M; Yamazaki Y; Kitagawa Y
    J Oral Sci; 2018; 60(1):159-162. PubMed ID: 29576576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Denosumab-associated osteonecrosis of the jaw--a case report.
    Vyas S; Hameed S; Murugaraj V
    Dent Update; 2014 Jun; 41(5):449-50. PubMed ID: 25073227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteonecrosis of the jaw in patients treated with denosumab: A multicenter case series.
    Aljohani S; Gaudin R; Weiser J; Tröltzsch M; Ehrenfeld M; Kaeppler G; Smeets R; Otto S
    J Craniomaxillofac Surg; 2018 Sep; 46(9):1515-1525. PubMed ID: 29983309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonate treatment as a cause of jaw osteonecrosis.
    Kanat O; Ozet A; Ataergin S; Kuzhan O; Arpaci F; Ozturk B; Komurcu S; Ozturk M
    Oral Dis; 2007 May; 13(3):346-7. PubMed ID: 17448221
    [No Abstract]   [Full Text] [Related]  

  • 20. The relationship of denosumab pharmacology and osteonecrosis of the jaws.
    Malan J; Ettinger K; Naumann E; Beirne OR
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Dec; 114(6):671-6. PubMed ID: 23159111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.